Team in Japan clears hurdle on way to trial of iPS cells

02/14/2013 | Japan Daily Press, The

An ethics panel at the Institute for Biomedical Research and Innovation in Japan has given the green light for a clinical trial of induced pluripotent stem cells in the treatment of age-related macular degeneration. If Japan's Health Ministry approves the six-patient trial, it could begin this fiscal year.

View Full Article in:

Japan Daily Press, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX